Sangamo Therapeutics Depreciation & Amortization 2011-2026 | SGMO

Annual Depreciation & Amortization Sangamo Therapeutics

2025	2024	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013	2012	2011
3.96 M	5.11 M	15.1 M	12.1 M	9.44 M	5.68 M	3.93 M	2.36 M	1.5 M	997 K	988 K	549 K	569 K	660 K	646 K

All numbers in USD currency

Indicator range from annual reports

Maximum	Minimum	Average
15.1 M	549 K	4.24 M

Quarterly Depreciation & Amortization Sangamo Therapeutics

2025-Q3	2025-Q2	2024-Q3	2024-Q2	2023-Q3	2023-Q2	2023-Q1	2022-Q4	2022-Q3	2022-Q2	2022-Q1	2021-Q4	2021-Q3	2021-Q2	2021-Q1	2020-Q4	2020-Q3	2020-Q2	2020-Q1	2019-Q4	2019-Q3	2019-Q2	2019-Q1	2018-Q4	2018-Q3	2018-Q2	2018-Q1	2017-Q4	2017-Q3	2017-Q2	2017-Q1	2016-Q4	2016-Q3	2016-Q2	2016-Q1	2015-Q4	2015-Q3	2015-Q2	2015-Q1	2014-Q4	2014-Q3	2014-Q2	2014-Q1	2013-Q4	2013-Q3	2013-Q2	2013-Q1	2012-Q4	2012-Q3	2012-Q2	2012-Q1	2011-Q4	2011-Q3	2011-Q2	2011-Q1
-	-	-	-	-	-	3.49 M	-	8.76 M	-	2.83 M	-	6.68 M	-	1.88 M	-	4 M	2.64 M	1.31 M	-	2.74 M	1.58 M	715 K	-	1.67 M	1.21 M	588 K	-	1.03 M	618 K	301 K	-	745 K	493 K	245 K	-	745 K	428 K	147 K	-	400 K	250 K	123 K	-	445 K	305 K	147 K	-	500 K	334 K	168 K	-	479 K	319 K	162 K

All numbers in USD currency

Indicator range from quarterly reporting

Maximum	Minimum	Average
8.76 M	123 K	1.38 M

Depreciation & Amortization of other stocks in the Biotechnology industry

Issuer	Depreciation & Amortization	Price	% 24h	Market Cap	Country
I-Mab IMAB	23.9 M	-	-	$ 866 M	China
Autolus Therapeutics plc AUTL	8.3 M	$ 1.36	-2.15 %	$ 362 M	Britain
Acorda Therapeutics ACOR	31.7 M	-	-24.86 %	$ 820 K	USA
Advaxis ADXS	369 K	-	-9.65 %	$ 45.9 M	USA
Adverum Biotechnologies ADVM	3.65 M	-	-	$ 86.2 M	USA
Aytu BioScience AYTU	5.38 M	$ 2.6	-2.26 %	$ 16.3 M	USA
Aeterna Zentaris AEZS	58 K	-	5.93 %	$ 314 M	Canada
AgeX Therapeutics AGE	100 K	-	-10.17 %	$ 12.2 K	USA
Aeglea BioTherapeutics AGLE	744 K	-	-	$ 1.01 B	USA
Applied Genetic Technologies Corporation AGTC	1.51 M	-	-	$ 26.5 M	USA
AIkido Pharma AIKI	105 K	-	1.93 %	$ 17.4 M	USA
Aptose Biosciences APTO	22 K	-	-45.71 %	$ 1.2 M	Canada
Akero Therapeutics AKRO	18 K	-	-	$ 3.67 B	USA
Coherus BioSciences CHRS	1.3 M	$ 1.62	-2.99 %	$ 190 M	USA
Akari Therapeutics, Plc AKTX	14 K	$ 3.5	-1.13 %	$ 236 B	Britain
Akouos AKUS	2.49 M	-	0.23 %	$ 488 M	USA
Allakos ALLK	6.14 M	-	-	$ 28.6 M	USA
Allena Pharmaceuticals ALNA	363 K	-	3.16 %	$ 1.9 M	USA
Alnylam Pharmaceuticals ALNY	55.7 M	$ 317.48	-3.89 %	$ 41.6 B	USA
Alpine Immune Sciences ALPN	597 K	-	-	$ 2.17 B	USA
Aileron Therapeutics ALRN	1 K	-	10.36 %	$ 9.8 M	USA
AlloVir ALVR	13 K	-	4.14 %	$ 49.1 M	USA
Atreca BCEL	5.46 M	-	-11.76 %	$ 5.79 M	USA
Ampio Pharmaceuticals AMPE	122 K	-	-11.43 %	$ 502 K	USA
IDEAYA Biosciences IDYA	2.7 M	$ 31.06	-3.96 %	$ 2.75 B	USA
Applied Molecular Transport AMTI	3.13 M	-	-	$ 10.1 M	USA
Aptorum Group Limited APM	1.13 M	$ 0.89	0.54 %	$ 4.85 M	China
Aptinyx APTX	122 K	-	-39.0 %	$ 4.57 M	USA
Cerus Corporation CERS	1.43 M	$ 1.85	-	$ 353 M	USA
AbbVie ABBV	762 M	$ 204.25	-1.15 %	$ 361 B	USA
Aquestive Therapeutics AQST	548 K	$ 4.03	-1.59 %	$ 431 M	USA
Aravive ARAV	886 K	-	-13.39 %	$ 1.45 M	USA
AbCellera Biologics ABCL	18.4 M	$ 3.26	-3.98 %	$ 974 M	Canada